Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications - A pilot study.
Moser, T; Otto, F; OSullivan, C; Hitzl, W; Pilz, G; Harrer, A; Trinka, E; Wipfler, P;
Mult Scler Relat Disord. 2022; 59: 103560
Originalarbeiten (Zeitschrift)

Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion.
Simon, D; Tascilar, K; Schmidt, K; Manger, B; Weckwerth, L; Sokolova, M; Bucci, L; Fagni, F; Manger, K; Schuch, F; Ronneberger, M; Hueber, A; Steffen, U; Mielenz, D; Herrmann, M; Harrer, T; Kleyer, A; Krönke, G; Schett, G;
Arthritis Rheumatol. 2022; 74(1):-37.
Originalarbeiten (Zeitschrift)

Two Cases of Severe Tick-Borne Encephalitis in Rituximab-Treated Patients in Germany: Implications for Diagnosis and Prevention
Steininger, PA; Bobinger, T; Dietrich, W; Lee, DH; Knott, M; Bogdan, C; Korn, K; Lang, R
OPEN FORUM INFECT DI. 2017; 4(4):
Übersichtsarbeiten